Stason Pharmaceuticals, Inc. recalls Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92…
- Recall date
- August 23, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1479-2016
- FDA classification
- Class III
- Brand / firm
- Stason Pharmaceuticals, Inc.
- Sold / distributed
- North Carolina
Why it was recalled
Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out of specification result for dissolution of stability samples.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: Stason Pharmaceuticals, Inc. Irvine, CA 92618 Distributed by: Libertas Pharma, Inc. Montgomery, AL 36117. NDC 51862-146-06
Get recall alerts
Free email alert whenever Stason Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Stason Pharmaceuticals, Inc.